Valproic acid induced liver injury: An insight into molecular toxicological mechanism
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Valproic acid induced liver injury: An insight into molecular toxicological mechanism
Authors
Keywords
-
Journal
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
Volume 95, Issue -, Pages 103967
Publisher
Elsevier BV
Online
2022-09-02
DOI
10.1016/j.etap.2022.103967
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Syringic acid and silymarin concurrent administration inhibits sodium valproate‐induced liver injury in rats
- (2022) Sukumaran Gheena et al. ENVIRONMENTAL TOXICOLOGY
- Valproic Acid-Induced Liver Injury: A Case-Control Study from a Prospective Pharmacovigilance Program in a Tertiary Hospital
- (2021) Enrique S. Meseguer et al. Journal of Clinical Medicine
- Mitochondria: A critical hub for hepatic stellate cells activation during chronic liver diseases
- (2021) Devaraj Ezhilarasan Hepatobiliary & Pancreatic Diseases International
- Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges
- (2021) Alison Jee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues
- (2021) Rolf Teschke et al. Annals of Translational Medicine
- Mitochondrial stress response in drug-induced liver injury
- (2021) Jing Zheng et al. MOLECULAR BIOLOGY REPORTS
- Taurine attenuates valproic acid-induced hepatotoxicity via modulation of RIPK1/RIPK3/MLKL-mediated necroptosis signaling in mice
- (2021) Mohammad Javad Khodayar et al. MOLECULAR BIOLOGY REPORTS
- Vitamin U prevents valproic acid-induced liver injury through supporting enzymatic antioxidant system and increasing hepatocyte proliferation triggered by inflammation and apoptosis
- (2021) Ertan Celik et al. TOXICOLOGY MECHANISMS AND METHODS
- Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease
- (2021) Tahar Hajri et al. Cells
- Protective effects of naringin on valproic acid-induced hepatotoxicity in rats
- (2021) Omer Faruk Koroglu et al. TISSUE & CELL
- Ellagic acid attenuates liver toxicity induced by valproic acid in rats
- (2020) Noha F. Abdelkader et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Obeticholic acid ameliorates Valproic acid-induced Hepatic Steatosis and Oxidative Stress
- (2020) Zhibo Gai et al. MOLECULAR PHARMACOLOGY
- Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
- (2020) Ze Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Valproic Acid-Induced Hyperammonemic Encephalopathy in a Patient with Bipolar Disorder: A Case Report
- (2020) Meng-Yu Wu et al. Brain Sciences
- Valproic acid promotes mitochondrial dysfunction in primary human hepatocytes in vitro; impact of C/EBPα-controlled gene expression
- (2020) F. Caiment et al. ARCHIVES OF TOXICOLOGY
- Valproate inhibits mitochondrial bioenergetics and increases glycolysis in Saccharomyces cerevisiae
- (2020) Michael Salsaa et al. Scientific Reports
- Models of Idiosyncratic Drug-Induced Liver Injury
- (2020) Tsuyoshi Yokoi et al. Annual Review of Pharmacology and Toxicology
- Valproic acid reverses Sorafenib resistance through inhibiting activated Notch/Akt signaling pathway in HCC
- (2020) Xu Yang et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Antioxidant and anti-inflammatory properties of alpha lipoic acid protect against valproic acid induced liver injury
- (2020) Marwa Abdeltawab Mohammed et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro
- (2020) Linfeng Ma et al. TOXICOLOGY
- Valproic Acid and the Liver Injury in Patients with Epilepsy: An update
- (2019) Hong-Li Guo et al. CURRENT PHARMACEUTICAL DESIGN
- Metabolomics reveals the effect of valproic acid on MCF-7 and MDA-MB-231 cells
- (2019) Xingzhi Zhou et al. XENOBIOTICA
- Drug-Induced Liver Injury — Types and Phenotypes
- (2019) Jay H. Hoofnagle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipidomic Profiling Reveals Disruption of Lipid Metabolism in Valproic Acid-Induced Hepatotoxicity
- (2019) Shansen Xu et al. Frontiers in Pharmacology
- Butyrate prevents valproate‐induced liver injury: In vitro and in vivo evidence
- (2019) Claudio Pirozzi et al. FASEB JOURNAL
- Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer
- (2019) Jie Sun et al. FEBS Journal
- Melatonin ameliorates sodium valproate-induced hepatotoxicity in rats
- (2019) Ozlem Oztopuz et al. MOLECULAR BIOLOGY REPORTS
- Ginsenoside compound K alleviates sodium valproate-induced hepatotoxicity in rats via antioxidant effect, regulation of peroxisome pathway and iron homeostasis
- (2019) Luping Zhou et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
- (2019) Lucy Meunier et al. Frontiers in Pharmacology
- A systematic review of population pharmacokinetics of valproic acid
- (2018) Janthima Methaneethorn BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Ether-phosphatidylcholine characterized by consolidated plasma and liver lipidomics is a predictive biomarker for valproic acid-induced hepatic steatosis
- (2018) Keisuke Goda et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction
- (2018) Simone G.J. van Breda et al. TOXICOLOGY
- Integrated ‘omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes
- (2018) Jarno E.J. Wolters et al. TOXICOLOGY LETTERS
- Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective
- (2018) Devaraj Ezhilarasan Arab Journal of Gastroenterology
- A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease
- (2018) Josephine Skat-Rørdam et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Agmatine protects against sodium valproate–induced hepatic injury in mice via modulation of nuclear factor‐κB/inducible nitric oxide synthetase pathway
- (2018) Nishat Ahmed et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- High-calorie diet inflates steatogenic effects of valproic acid in mice
- (2016) Chandrasekaran Sathiya Priya et al. TOXICOLOGY MECHANISMS AND METHODS
- High-calorie diet inflates steatogenic effects of valproic acid in mice
- (2016) Chandrasekaran Sathiya Priya et al. TOXICOLOGY MECHANISMS AND METHODS
- Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat
- (2015) Sabbir Khan et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells
- (2015) KOJI YAMANEGI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis
- (2015) Li-Fong Seet et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Valproate-Induced Liver Injury: Modulation by the Omega-3 Fatty Acid DHA Proposes a Novel Anticonvulsant Regimen
- (2014) Marwa A. Abdel-Dayem et al. Drugs in research & development
- Adverse drug reactions induced by valproic acid
- (2013) Radu M. Nanau et al. CLINICAL BIOCHEMISTRY
- Drug-Induced Liver Injury from Antiepileptic Drugs
- (2013) Jennifer S. Au et al. Clinics in Liver Disease
- Valproic acid pathway
- (2013) Yogita Ghodke-Puranik et al. Pharmacogenetics and Genomics
- Toxicity of valproic acid in isolated rat liver mitochondria
- (2013) Iman Jafarian et al. TOXICOLOGY MECHANISMS AND METHODS
- Effects of vitamin U (S-methyl methionine sulphonium chloride) on valproic acid induced liver injury in rats
- (2012) Bahar Bilgin Sokmen et al. FOOD AND CHEMICAL TOXICOLOGY
- A new approach on valproic acid induced hepatotoxicity: Involvement of lysosomal membrane leakiness and cellular proteolysis
- (2012) Jalal Pourahmad et al. TOXICOLOGY IN VITRO
- Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: Dynamic synergy and therapeutic utility
- (2011) A.M. El-Mowafy et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Glutathione depletion by valproic acid in sandwich-cultured rat hepatocytes: Role of biotransformation and temporal relationship with onset of toxicity
- (2011) Tony K.L. Kiang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- TNF-α-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL
- (2010) J J Kim et al. CELL DEATH AND DIFFERENTIATION
- Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study
- (2010) Adrian Reuben et al. HEPATOLOGY
- Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver
- (2010) Karima Begriche et al. JOURNAL OF HEPATOLOGY
- POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders
- (2010) Russell P. Saneto et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis
- (2009) Cátia C.P. Aires et al. BIOCHEMICAL PHARMACOLOGY
- Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment
- (2009) G. Luef et al. EPILEPSY RESEARCH
- Nonalcoholic fatty liver disease during valproate therapy
- (2009) Alberto Verrotti et al. EUROPEAN JOURNAL OF PEDIATRICS
- Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
- (2009) Kimford J. Meador et al. NEW ENGLAND JOURNAL OF MEDICINE
- TNFα and reactive oxygen species in necrotic cell death
- (2008) Michael J Morgan et al. CELL RESEARCH
- Effect of Aging on Glucuronidation of Valproic Acid in Human Liver Microsomes and the Role of UDP-Glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10
- (2008) U. A. Argikar et al. DRUG METABOLISM AND DISPOSITION
- Status epilepticus in children with Alpers’ disease caused byPOLG1mutations: EEG and MRI features
- (2008) Nicole I. Wolf et al. EPILEPSIA
- 155th ENMC workshop: Polymerase gamma and disorders of mitochondrial DNA synthesis, 21–23 September 2007, Naarden, The Netherlands
- (2007) Patrick F. Chinnery et al. NEUROMUSCULAR DISORDERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started